Andrey E. Belykh

Andrey E. Belykh

Auto-generated profile, based on publicly available information

Andrey E. Belykh

Dioscuri Centre for Metabolic Diseases, Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Biomarker Insights
Verified
Journal Article
Open access
OPOlesya A Puchenkova
Olesya A Puchenkova
VSVladislav Soldatov
Vladislav Soldatov
ABAndrei E Belykh
Andrei E Belykh
OBOlgaYu Bushueva
OlgaYu Bushueva
Gennadii PiavchenkoGennadii Piavchenko
Gennadii Piavchenko
MPMikhail V Pokrovskiy
Mikhail V Pokrovskiy
Abdominal aortic aneurysm (AAA) is a potentially life-threatening disorder with a mostly asymptomatic course where the abdominal aorta is weakened and bulged. Cytokines play especially important roles (both positive and negative) among the molecular actors of AAA development. All the inflammatory cascades, extracellular matrix degradation and vascular smooth muscle cell apoptosis are driven by cytokines. Previous studies emphasize an altered expression and a changed epigenetic regulation of key cytokines in AAA tissue samples. Such cytokines as IL-6, IL-10, IL-12, IL-17, IL-33, IL-1β, TGF-β, TNF-α, IFN-γ, and CXCL10 seem to be crucial in AAA pathogenesis. Some data obtained in animal studies show a protective function of IL-10, IL-33, and canonical TGF-β signaling, as well as a dual role of IL-4, IFN-γ and CXCL10, while TNF-α, IL-1β, IL-6, IL-12/IL-23, IL-17, CCR2, CXCR2, CXCR4 and the TGF-β noncanonical pathway are believed to aggravate the disease. Altogether data highlight significance of cytokines as informative markers and predictors of AAA. Pathologic serum/plasma concentrations of IL-1β, IL-2, IL-6, TNF-α, IL-10, IL-8, IL-17, IFN-γ, and PDGF have been already found in AAA patients. Some of the changes correlate with the size of aneurysms. Moreover, the risk of AAA is associated with polymorphic variants of genes encoding cytokines and their receptors: CCR2 (rs1799864), CCR5 (Delta-32), IL6 (rs1800796 and rs1800795), IL6R (rs12133641), IL10 (rs1800896), TGFB1 (rs1800469), TGFBR1 (rs1626340), TGFBR2 (rs1036095, rs4522809, rs1078985), and TNFA (rs1800629). Finally, 5 single-nucleotide polymorphisms in gene coding latent TGF-β-binding protein ( LTBP4) and an allelic variant of TGFB3 are related to a significantly slower AAA annual growth rate.

5 December 2022 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
VSVladislav Soldatov
Vladislav Soldatov
MKMarina Kubekina
Marina Kubekina
MSMarina Yu. Skorkina
Marina Yu. Skorkina
ABAndrei E. Belykh
Andrei E. Belykh
TETatiana Egorova
Tatiana Egorova
Plamena R. AngelovaPlamena R. Angelova
Plamena R. Angelova
Mitochondrial diseases (MD) are a heterogeneous group of multisystem disorders involving metabolic errors. MD are characterized by extremely heterogeneous symptoms, ranging from organ-specific to multisystem dysfunction with different clinical courses. Most primary MD are autosomal recessive but maternal inheritance (from mtDNA), autosomal dominant, and X-linked inheritance is also known. Mitochondria are unique energy-generating cellular organelles designed to survive and contain their own unique genetic coding material, a circular mtDNA fragment of approximately 16,000 base pairs. The mitochondrial genetic system incorporates closely interacting bi-genomic factors encoded by the nuclear and mitochondrial genomes. Understanding the dynamics of mitochondrial genetics supporting mitochondrial biogenesis is especially important for the development of strategies for the treatment of rare and difficult-to-diagnose diseases. Gene therapy is one of the methods for correcting mitochondrial disorders.Graphical Abstract

1 May 2021 in Eye and Brain
Verified
Journal Article
Open access
PDF file
VSVladislav Soldatov
Vladislav Soldatov
MKMichail S Kukharsky
Michail S Kukharsky
ABAndrey E Belykh
Andrey E Belykh
ASAndrey M Sobolev
Andrey M Sobolev
ADAlexey V Deykin
Alexey V Deykin
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease resulting in a gradual loss of motor neuron function. Although ophthalmic complaints are not presently considered a classic symptom of ALS, retinal changes such as thinning, axonal degeneration and inclusion bodies have been found in many patients. Retinal abnormalities observed in postmortem human tissues and animal models are similar to spinal cord changes in ALS. These findings are not dramatically unexpected because retina shares an ontogenetic relationship with the brain, and many genes are associated both with neurodegeneration and retinal diseases. Experimental studies have demonstrated that ALS affects many “vulnerable points” of the retina. Aggregate deposition, impaired nuclear protein import, endoplasmic reticulum stress, glutamate excitotoxicity, vascular regression, and mitochondrial dysfunction are factors suspected as being the main cause of motor neuron damage in ALS. Herein, we show that all of these pathways can affect retinal cells in the same way as motor neurons. Furthermore, we suppose that understanding the patterns of neuro-ophthalmic interaction in ALS can help in the diagnosis and treatment of this disease.

17 April 2021 in Journal of Molecular Neuroscience
Verified
Journal Article
Closed access
PDF file
OBOlga Bushueva
Olga Bushueva
EBEkaterina Barysheva
Ekaterina Barysheva
AMAnton Markov
Anton Markov
ABAndrey Belykh
Andrey Belykh
Iuliia A. KorolevaIuliia A. Koroleva
Iuliia A. Koroleva
NMNazarenko Maria
Nazarenko Maria

25 July 2023 in EMBO Molecular Medicine
Verified
Journal Article
Open access
TKTill Karwen
Till Karwen
KKKatarzyna Kolczynska‐Matysiak
Katarzyna Kolczynska‐Matysiak
CGCarina Gross
Carina Gross
MLMona C Löffler
Mona C Löffler
MFMike Friedrich
Mike Friedrich
GSGrzegorz Sumara
Grzegorz Sumara
Hyperreactive platelets are commonly observed in diabetic patients indicating a potential link between glucose homeostasis and platelet reactivity. This raises the possibility that platelets may play a role in the regulation of metabolism. Pancreatic β cells are the central regulators of systemic glucose homeostasis. Here, we show that factor(s) derived from β cells stimulate platelet activity and platelets selectively localize to the vascular endothelium of pancreatic islets. Both depletion of platelets and ablation of major platelet adhesion or activation pathways consistently resulted in impaired glucose tolerance and decreased circulating insulin levels. Furthermore, we found platelet‐derived lipid classes to promote insulin secretion and identified 20‐Hydroxyeicosatetraenoic acid (20‐HETE) as the main factor promoting β cells function. Finally, we demonstrate that the levels of platelet‐derived 20‐HETE decline with age and that this parallels with reduced impact of platelets on β cell function. Our findings identify an unexpected function of platelets in the regulation of insulin secretion and glucose metabolism, which promotes metabolic fitness in young individuals.

23 April 2015 in Bulletin of Experimental Biology and Medicine
Verified
Journal Article
Closed access
PDF file
IBI. I. Bobyntsev
I. I. Bobyntsev
OCO. I. Chernysheva
O. I. Chernysheva
MDM. E. Dolgintsev
M. E. Dolgintsev
MSM. Yu. Smakhtin
M. Yu. Smakhtin
ABA. E. Belykh
A. E. Belykh